JADPRO Live 2019 Certified Educational Activities

Earn CE credit with these certified educational activities based on presentations from JADPRO Live 2019. Access the full-length presentation (where available), the slide deck and transcript. You can earn CE for each of these activities by following the links.

Click on any of the presentations below to get started!

Integrating Best Practices to Improve Outcomes in Relapsed/Refractory Multiple Myeloma

Listen as two multiple myeloma experts break down the approved and emerging treatment options for relapsed/refractory multiple myeloma, including mechanisms of action, supporting clinical data, and associated adverse events, ​and discover best practices for selecting and sequencing therapy​.

Posted: February 15, 2020 / Expires: February 14, 2021

Estimated time to complete: 1.5 hours

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Precision Oncology Comes of Age: Tumor-Agnostic Approaches

Guided by two experts in the field, dive into the new world of tumor-agnostic treatment approaches, including those aimed at managing patients with tumors that have high microsatellite instability (MSI-H) or neurotrophic receptor tyrosine kinase (NTRK) fusions. Learn about the clinical trial designs that enable development of these novel therapies, and discover how testing methodologies support the advancement of precision medicine.

Posted: February 15, 2020 / Expires: February 14, 2021

Estimated time to complete: .75 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


New Drug Updates: Hematologic Malignancies

Get updated on the FDA-approved therapies for initial or expanded indications for hematologic malignancies across the past year, as well as their supporting clinical trial data and best practices for safe and effective dosing and administration, drug monitoring, and adverse event management.

Posted: February 15, 2020 / Expires: February 14, 2021

Estimated time to complete: 0.75 hours

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Addressing the Challenges of Aggressive Lymphomas

Learn how to tackle challenges in the treatment of aggressive lymphomas by understanding how to apply emerging data, reviewing optimal therapies and treatment recommendations, and discovering how to manage associated adverse events in this disease state.

Posted: February 15, 2020 / Expires: February 14, 2021

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


First-Line Therapy for Metastatic Non-Small Cell Lung Cancer: State-of-the-Art Targeted Therapy and Immunotherapy Approaches

Hone your ability to devise first-line treatment plans for patients with metastatic non–small cell lung cancer, including using biomarkers to guide treatment selection, understanding clinical data supporting use of targeted and immune checkpoint inhibitor therapies, and managing associated adverse events.

Posted: February 15, 2020 / Expires: February 14, 2021

Estimated time to complete: 1.5 hours

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Creating Clarity in Metastatic Melanoma: Optimizing Treatment and Improving Outcomes

Take a deep dive into the diagnosis and treatment landscape for metastatic melanoma, including clinicopathologic features of the disease, approved and emerging therapeutics, and strategies for integrating contemporary standard-of-care management practices. Plus, discover best practices for enhancing collaboration and communication within a multidisciplinary, interprofessional team that fosters shared decision-making.

Posted: February 15, 2020 / Expires: February 14, 2021

Estimated time to complete: 1.5 hours

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Expert Insights on Triple-Negative Breast Cancer: Preparing for the Next Wave of Treatments

Learn from two experts in the field of breast cancer as they discuss the current and future treatment landscape for triple-negative breast cancer, including recent and emerging data on approved treatments, novel therapeutic options being investigated, and best practices for identifying and monitoring adverse events associated with PARP and immune checkpoint inhibitors.

Posted: February 15, 2020 / Expires: February 14, 2021

Estimated time to complete: 1.5 hours

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Biomarker BINGO

Test your knowledge on biomarkers and their use in determining targeted therapy for certain tumor types, key assays used to measure common biomarkers, and guideline-endorsed biomarker testing recommendations.

Posted: February 15, 2020 / Expires: February 14, 2021

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Current and Future Directions in PARP Inhibition

Review how far PARP inhibition has come and discover where it’s headed, including its potential role in various malignancies, how to select patients who are appropriate candidates, and guidance on devising treatment plans that include PARP inhibitors for patients with ovarian or breast cancer based on genetic profiles, tolerability, dosing schedules, and other factors.

Posted: February 15, 2020 / Expires: February 14, 2021

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Recent Advances in the Treatment of Newly Diagnosed Multiple Myeloma

Watch as two experts in the field of multiple myeloma (MM) interpret data on current and novel treatments, discuss how to select initial therapy based on patient risk and in alignment with guidelines and best practices, and evaluate the use of minimal residual disease testing in patients with MM.

Posted: February 15, 2020 / Expires: February 14, 2021

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Immune Checkpoint Inhibitor-Based Therapy as a Backbone in Cancer Treatment

Review the basic concepts of immunotherapy and the current treatment landscape; explore important aspects of IO care, including the microbiome, provider-patient communication, and survivorship; and evaluate emerging data for ICI-based combinations that are being explored in late-stage clinical trials.

Posted: February 15, 2020 / Expires: February 14, 2021

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Adoptive Cell Therapies: Keeping Pace With New and Emerging Advances

Discover the emerging world of chimeric antigen receptor (CAR) T-cell therapy, including the CAR T-cell process, approved indications and studies in hematologic malignancies, strategies for monitoring and managing emerging toxicities, and future directions in the use of this novel therapy.

Posted: February 15, 2020 / Expires: February 14, 2021

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Improving Outcomes for Patients With Chronic Lymphocytic Leukemia

Review data regarding mechanistic activity, efficacy, and safety of approved and emerging therapeutic options for chronic lymphocytic leukemia (CLL), discover how to devise risk-stratified treatment plans, and learn strategies for managing adverse events associated with approved therapies for CLL.

Posted: February 15, 2020 / Expires: February 14, 2021

Estimated time to complete: 1.5 hours

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Improving Outcomes for Patients With Advanced Urothelial Carcinoma of the Bladder

Discover how to select appropriate lines of therapy for treatment of advanced or metastatic urothelial carcinoma and manage associated adverse events in accordance with evidence-based best practices, and learn what’s on the horizon in the treatment of this disease state.

Posted: February 15, 2020 / Expires: February 14, 2021

Estimated time to complete: 1.5 hours

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Improving Outcomes in HER2+ Breast Cancer: Analysis and Application of Evolving Data and Best Practices

Through expert, case-based discussion, learn about existing and emerging data for current and investigational therapies for HER2+ breast cancer and their associated adverse events, in addition to best practices for managing central nervous system metastases.

Posted: February 15, 2020 / Expires: February 14, 2021

Estimated time to complete: 1.5 hours

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Non-Certified Video


Second Annual Mary Pazdur Award for Excellence in Advanced Practice in Oncology

Tina Harris, MS, NP-C, AOCNP, Chair of the APSHO Awards Committee, and Jack Gentile, Chairman of Harborside, present Jody Pelusi, PhD, FNP, AOCNP, with the Mary Pazdur Award, which recognizes and honors a member of the Advanced Practitioner Society for Hematology and Oncology (APSHO) who demonstrates exemplary leadership and makes outstanding contributions in areas of clinical practice, research, education, collaboration, and mentorship. Learn more at http://marypazduraward.com/.

Watch Video Without Claiming Credit

 
These activities, certified for CME/CE/CPE credit, are jointly provided by

Annenberg Logo Harborside Press Logo

Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.